Donor MultiTAA-Specific T Cells

· Baylor College of Medicine

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Donor MultiTAA-Specific T Cells, covering 2024-12-06 to 2024-12-06. Get the full timeline:

Most recent: Clinical Trial Update: Administration of Donor MultiTAA-Specific T Cells for ALL [Phase 1]